期刊文献+

脑多巴胺转运体单光子发射型计算机断层显像在诊断帕金森病中的应用 被引量:1

The application of brain dopamine transporter ^(99)Tc^m-TRODAT-1 SPECT imaging in diagnosis of PD
下载PDF
导出
摘要 目的探讨脑多巴胺转运体显像剂99Tcm-TRODAT-1在基底神经节的分布特点,以及单光子发射型计算机断层显像(SPECT)对诊断帕金森病(PD)的价值。方法将35例PD患者(PD组)和16例健康体检者(对照组)进行99Tcm-TRODAT-1 SPECT脑显像检查。以半定量方法分析,应用计算机感兴趣区(ROI)技术计算双侧横断位、矢状位纹状体(ST)/小脑(CB)放射性摄取率之比。结果对照组横断位左右侧和矢状位左、右侧ST/CB分别为(1.55±0.15)、(1.58±0.14)和(1.62±0.17)、(1.69±0.16)。PD组ST/CB比对照组明显减低,差异有显著性意义(P<0.01)。结论99Tcm-TRODAT-1在SPECT中显像是诊断PD的有效方法。 Objective To investigate the characteristics of distribution of ^99Tc^m-TRODAT-1 in the basal ganglia and evaluate the value of SPECT imaging in diagnosis of Parkinson's disease (PD). Methods ^99Tc^m-TRODAT-1 SPECT imaging was used in 35 PD patients and sixteen age-matched healthy volunteers. The regions of interest were drawn manually on cerebellum (CB) ,three transverse,and sagittal plane slice-views of striatums(ST). The uptake ratios of ST/CB were calculated using semiquantitative analysis. Results The ST/CB ratios of left and right transverse planes and sagittal planes in healthy volunteers were 1.55±0.15,1.58±0.14,1.62±0.17 and 1.69±0. 16 respectively. A lower specific uptake of ^99Tc^m-TRODAT-1 in striatums was displayed in 35 PD patients by visual inspection,compared with healthy volunteers. The uptake ratios ST/CB in the basal ganglia of PD were significantly lower than those of healthy volunteers ( P 〈0.01 ). Conclusion ^99Tc^m-TRODAT-1 SPECT imaging is an effective method for diagnosis of PD.
作者 唐静 杨健
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2007年第9期608-610,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 广东省卫生厅医学科学技术研究基金资助(A2001515)
关键词 帕金森病 多巴胺 体层摄影术 发射型计算机 单光子 Parkinson disease dopamine tomography, emission-computed, single-photon
  • 相关文献

参考文献5

二级参考文献23

  • 1Leenders KL,Salmon EP,et al.The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease[J].Arch Neurol,1990,47(12):1290-1298.
  • 2Nutt JG,Carter JH,Sexton GJ.The dopamine transporter:importance in Parkinson's disease[J].Ann Neurol,2004,55(6):766-773.
  • 3Becker G.Methods for the early diagnosis of Parkinson's disease[J].Nervenarzt,2003,74 (Suppl):S7-11.
  • 4Davis MR,Votaw JR,Bremner JD,et al.Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT[J].J Nucl Med,2003,44(6):855-861.
  • 5Chou KL,Hurtig HI,Stern MB,et al.Diagnostic accuracy of[^99Tc^m]TRODAT-1 SPECT imaging in early Parkinson's disease[J].Parkinsonism Relat Disord,2004,10(6):375-379.
  • 6Huang WS,Lee MS,Lin JC,et al.Usefulness of brain ^99Tc^m-TRODAT-1 SPET for the evaluation of Parkinson's disease[J].Eur J Nucl Med Mol Imaging,2004,31(2):155-161.
  • 7Maraganore DM,O'Connor MK,Bower JH,et al.Detection of preclinical Parkinson's disease in at risk family members with use of ^123I-β-CIT and SPECT:an exploratory study[J].Mayo Clinic Proceedings,1999,74(7):681-685.
  • 8Simpkins N,Jankovic J.Neuroprotection in Parkinson disease[J].Arch Intern Med,2003,163(14):1650-1654.
  • 9Lynch DR,Mozley PD,Sokol S,et al.Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease[J].Mov Disord,2003,18(7):804-812.
  • 10Tzen KY,Lu CS,Yen TC,et al.Differential diagnosis of Parkinson's disease and vascular parkinsonism by ^99Tc^m-TRODAT-1[J].J Nucl Med,2001,42(3):408-413.

共引文献18

同被引文献12

  • 1Thomas F,Carol B,Roger A.The heterogeneity of idiopathic Parkinson's disease.J Neurol,2002,249:138-145.
  • 2Lohle M,Storch A,Reichmann H.Beyond tremor and rigidity:non-motor features of Parkinson's disease.J Neural Transm,2009,116:1483-1492.
  • 3王丽敏,王丽娟.帕金森病的神经功能影像学//陈生弟.帕金森病.北京:人民卫生出版社,2006.209-220.
  • 4Katzen HL,Levin BE,Weiner W.Side and type of motor symptom influence cognition in Parkinson's disease.Mov Disord,2006,21:1947-1953.
  • 5Selikhova M,Williams DR,Kempster PA,et al.A clinicopathological study of subtypes in Parkinson's disease.Brain,2009,132(Pt 11):2947-2957.
  • 6Alves G,Larsen JP,Emre M,et al.Changes in motor subtype and risk for incident dementia in Parkinson's disease.Mov Disord,2006,21:1123-1130.
  • 7Maetzler W,Liepelt I,Berg D.Progression of Parkinson's disease in the clinical phase:potential markers.Lancet Neurol,2009,8:1158-1171.
  • 8Ling H,Lees AJ.How can neuroimaging help in the diagnosis of movement disorders.Neuroimaging Clin North Am,2010,20:111-123.
  • 9Kung HF,Kung MP,Wey SP.Clinical acceptance of a molecular imaging agent:a long march with 99mTc-TRODAT.Nucl Med Biol.2007,34:787-789.
  • 10Post B,Merkus MP,de Haan RJ,et al.Prognostic factors for the progression of Parkinson's discase:a systematic review.Mov Disord,2007,22:1839-1851.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部